Elucidating the role of Trp105 in the KPC-2 β-lactamase

Substrate Selectivity and a Novel Role in Inhibitor Discrimination by Residue 237 in the KPC-2  -Lactamase

(2010) K. M. Papp-Wallace et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evolving Carbapenemases: Can Medicinal Chemists Advance One Step Ahead of the Coming Storm?

(2010) Peter Oelschlaeger et al.   JOURNAL OF MEDICINAL CHEMISTRY

Novel Ambler Class A Carbapenem-Hydrolyzing  -Lactamase from a Pseudomonas fluorescens Isolate from the Seine River, Paris, France

(2009) D. Girlich et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Hydrolysis and Inhibition Profiles of  -Lactamases from Molecular Classes A to D with Doripenem, Imipenem, and Meropenem

(2009) A. M. Queenan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Inhibitor Resistance in the KPC-2  -Lactamase, a Preeminent Property of This Class A  -Lactamase

(2009) K. M. Papp-Wallace et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA

(2009) Andrea Endimiani et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Mechanistic Basis for the Emergence of Catalytic Competence against Carbapenem Antibiotics by the GES Family of β-Lactamases

(2009) Hilary Frase et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Genetic and Structural Insights into the Dissemination Potential of the Extremely Broad-Spectrum Class A  -Lactamase KPC-2 Identified in an Escherichia coli Strain and an Enterobacter cloacae Strain Isolated from the Same Patient in France

(2008) S. Petrella et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

New developments in carbapenems

(2008) J.N. Kattan et al.   CLINICAL MICROBIOLOGY AND INFECTION